ROS Regulation in CNS Disorder Therapy: Unveiling the Dual Roles of Nanomedicine
Authors:
Abstract
The treatment of brain diseases has always been the focus of attention. Due to the presence of the blood‐brain barrier (BBB), most small molecule drugs are difficult to reach the brain, leading to undesirable therapeutic outcomes. Recently, nanomedicines that can cross the BBB and precisely target lesion sites have emerged as thrilling tools to enhance the early diagnosis and treat various intractable brain disorders. Extensive research has shown that reactive oxygen species (ROS) play a crucial role in the occurrence and progression of brain diseases, including brain tumors and neurodegenerative diseases (NDDs) such as Alzheimer's disease, Parkinson's disease, stroke, or traumatic brain injury, making ROS a potential therapeutic target. In this review, on the structure and function of BBB as well as the mechanisms are first elaborated through which nanomedicine traverses it. Then, recent studies on ROS production are summarized through photodynamic therapy (PDT), chemodynamic therapy (CDT), and sonodynamic therapy (SDT) for treating brain tumors, and ROS depletion for treating NDDs. This provides valuable guidance for the future design of ROS‐targeted nanomedicines for brain disease treatment. The ongoing challenges and future perspectives in developing nanomedicine‐based ROS management for brain diseases are also discussed and outlined.Keywords
Funding Information
- National Natural Science Foundation of China (32371442)
This publication has 215 references indexed in Scilit:
- The Role of Reactive Oxygen Species in Alzheimer's Disease: From Mechanism to Biomaterials TherapyAdvanced Healthcare Materials, 2024
- Quintuple Free‐Radical Therapy: An Ultralong‐Retention FAND for NIR‐Involved Multiple Site‐Acting Hypoxic Tumor TherapyAdvanced Functional Materials, 2024
- Insights into Targeted and Stimulus‐Responsive Nanocarriers for Brain Cancer TreatmentAdvanced Healthcare Materials, 2024
- Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel DiseaseAdvanced Healthcare Materials, 2023
- Engineering Macrophage Exosome Disguised Biodegradable Nanoplatform for Enhanced Sonodynamic Therapy of GlioblastomaAdvanced Materials, 2022
- A Novel Targeted Nanoparticle for Traumatic Brain Injury Treatment: Combined Effect of ROS Depletion and Calcium Overload InhibitionAdvanced Healthcare Materials, 2022
- In Situ Sprayed Starvation/Chemodynamic Therapeutic Gel for Post‐Surgical Treatment of IDH1 (R132H) GliomaAdvanced Materials, 2021
- Reversing Aβ Fibrillation and Inhibiting Aβ Primary Neuronal Cell Toxicity Using Amphiphilic Polyphenylene DendronsAdvanced Healthcare Materials, 2021
- Catalytic‐Enhanced Lactoferrin‐Functionalized Au‐Bi2Se3 Nanodots for Parkinson's Disease Therapy via Reactive Oxygen Attenuation and Mitochondrial ProtectionAdvanced Healthcare Materials, 2021
- Biomimetic Nanomaterial Strategies for Virus Targeting: Antiviral Therapies and VaccinesAdvanced Functional Materials, 2020